Filing Details
- Accession Number:
- 0000899243-19-024045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-23 15:51:46
- Reporting Period:
- 2019-09-20
- Accepted Time:
- 2019-09-23 15:51:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1728117 | Gossamer Bio Inc. | GOSS | () | E9 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1641348 | Omega Fund V Gp Manager, Ltd. | 888 Boylston Street, Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1641354 | Omega Fund V, L.p. | 888 Boylston Street, Suite 1111 Boston MA 02199 | No | No | Yes | No | |
1641355 | Omega Fund V Gp, L.p. | 888 Boylston Street, Suite 1111 Boston MA 02199 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-09-20 | 183,607 | $21.96 | 6,553,416 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $22.19 per share, inclusive.
- The reported securities are held directly by Omega Fund V, L.P. ("Omega V"). The reported securities may be deemed to be beneficially owned by each of Omega Fund V GP, L.P. ("Omega V GP"), as the general partner of Omega V, and Omega Fund V GP Manager, Ltd. ("Omega V GP Manager"), as the general partner of Omega V GP. Otello Stampacchia, Richard Lim, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega V GP Manager and have shared voting and investment power over the shares held by Omega V. Each of Omega V GP, Omega Fund V GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any.
- After completing the transactions reported above, none of the reporting persons, directly or indirectly, hold 10% or more of the issuer's outstanding Common Stock.